8-K
Current Report
Compass Therapeutics, Inc. Filed Acc 0001193125-25-179958
Material agreement · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading d153873d8k.htm…